FULC
Price
$4.44
Change
-$0.03 (-0.67%)
Updated
Sep 29, 6:59 PM EST
46 days until earnings call
SLS
Price
$1.64
Change
-$0.03 (-1.80%)
Updated
Sep 29, 6:59 PM EST
47 days until earnings call

Compare predictions FULC vs SLS

Header iconFULC vs SLS Comparison
Open Charts FULC vs SLSBanner chart's image
Fulcrum Therapeutics
Price$4.44
Change-$0.03 (-0.67%)
Volume$188.99K
CapitalizationN/A
SELLAS Life Sciences Group
Price$1.64
Change-$0.03 (-1.80%)
Volume$158.69K
CapitalizationN/A
View a ticker or compare two or three
FULC vs SLS Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
FULC vs. SLS commentary
Sep 30, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FULC is a Hold and SLS is a StrongBuy.

COMPARISON
Comparison
Sep 30, 2023
Stock price -- (FULC: $4.43 vs. SLS: $1.63)
Brand notoriety: FULC and SLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FULC: 15% vs. SLS: 169%
Market capitalization -- FULC: $276.35M vs. SLS: $46.21M
FULC [@Biotechnology] is valued at $276.35M. SLS’s [@Biotechnology] market capitalization is $46.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 0 FA rating(s) are green whileSLS’s FA Score has 0 green FA rating(s).

  • FULC’s FA Score: 0 green, 5 red.
  • SLS’s FA Score: 0 green, 5 red.
According to our system of comparison, FULC is a better buy in the long-term than SLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 3 TA indicator(s) are bullish while SLS’s TA Score has 5 bullish TA indicator(s).

  • FULC’s TA Score: 3 bullish, 7 bearish.
  • SLS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SLS is a better buy in the short-term than FULC.

Price Growth

FULC (@Biotechnology) experienced а +6.12% price change this week, while SLS (@Biotechnology) price change was +7.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was +23.15%, and the average quarterly price growth was +41.71%.

Reported Earning Dates

FULC is expected to report earnings on Nov 15, 2023.

SLS is expected to report earnings on Nov 16, 2023.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FULC with price predictions.
OPEN
A.I.dvisor published
a Summary for SLS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FULC($276M) has a higher market cap than SLS($46.2M). SLS YTD gains are higher at: -30.932 vs. FULC (-39.217). SLS has higher annual earnings (EBITDA): -46.92M vs. FULC (-104.8M). FULC has more cash in the bank: 278M vs. SLS (13.8M). SLS has less debt than FULC: SLS (749K) vs FULC (12.2M). FULC has higher revenues than SLS: FULC (3.04M) vs SLS (0).
FULCSLSFULC / SLS
Capitalization276M46.2M597%
EBITDA-104.8M-46.92M223%
Gain YTD-39.217-30.932127%
P/E RatioN/AN/A-
Revenue3.04M0-
Total Cash278M13.8M2,014%
Total Debt12.2M749K1,629%
FUNDAMENTALS RATINGS
SLS: Fundamental Ratings
SLS
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FULCSLS
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGTX1.470.10
+7.30%
Cognition Therapeutics
NOVT143.44-0.57
-0.40%
Novanta
PM92.58-0.47
-0.51%
Philip Morris International
XNCR20.15-0.35
-1.71%
Xencor
UTI8.38-0.37
-4.23%
Universal Technical Institute

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with NKTR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then NKTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
-1.01%
NKTR - FULC
49%
Loosely correlated
-3.26%
SLS - FULC
47%
Loosely correlated
-2.40%
SRNEQ - FULC
34%
Loosely correlated
-6.19%
AXON - FULC
33%
Poorly correlated
+1.48%
SGMO - FULC
33%
Poorly correlated
+3.90%
More